Literature DB >> 30266639

Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam.

Van Huy Tran1, Thi Minh Thi Ha2, Phan Tuong Quynh Le3, Trung Nam Phan4, Thi Nhu Hoa Tran5.   

Abstract

OBJECTIVES: The prevalence of clarithromycin (CLR)-resistant Helicobacter pylori is increasing worldwide, including in Vietnam. The aims of this study were to determine point mutations in the 23S rRNA domain V of clinical H. pylori strains in central Vietnam, to estimate the prevalence of phenotypic CLR resistance and to assess the association between 23S rRNA domain V genotype and CLR-resistant phenotype.
METHODS: Sequencing of the 23S rRNA domain V of H. pylori strains from gastric biopsy specimens was performed for 185 patients with H. pylori-positive chronic gastritis, of which 104 samples were subjected to susceptibility testing to determine CLR resistance.
RESULTS: A total of 24 types of point mutation were detected. A2143G and A2142G mutations were observed in 40.5% and 4.3%, respectively. New point mutations were detected (C2041T, C2083T, C2191T, G2220A, G2225A, G2240A, C2273T, T2276C, G2287A, C2399T, A2445G and C2622T). 23S rRNA domain V genotypes were diversified, with combinations of two or more point mutations as well as single point mutations. The rate of phenotypic CLR resistance was 53.8%, increasing from 40.4% in 2012-2014 to 70.2% in 2015-2017 (P=0.0045). A2143G and A2142G accounted for 89.3% of phenotypically CLR-resistant H. pylori isolates.
CONCLUSIONS: A diversity of point mutations in the 23S rRNA domain V was observed in clinical H. pylori isolates. The rate of phenotypically CLR-resistant H. pylori is significantly increasing in central Vietnam. Further research is necessary to clarify the role of the combination of 23S rRNA domain V mutations in the molecular mechanism of CLR resistance.
Copyright © 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  23S rRNA domain V mutation; Clarithromycin resistance; Helicobacter pylori

Mesh:

Substances:

Year:  2018        PMID: 30266639     DOI: 10.1016/j.jgar.2018.09.012

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  4 in total

Review 1.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

2.  Characterization of Domain V Mutations in Clinical Isolates of Helicobacter pylori in Pakistan and Their Effect on Clarithromycin MIC.

Authors:  Shumaiza Anis; Shakeel R Farooqi; Saad K Niaz
Journal:  Infect Drug Resist       Date:  2021-08-24       Impact factor: 4.003

Review 3.  Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches.

Authors:  Andreia T Marques; Jorge M B Vítor; Andrea Santos; Mónica Oleastro; Filipa F Vale
Journal:  Microb Genom       Date:  2020-03

4.  Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam.

Authors:  Trung Thien Tran; Anh Tuan Nguyen; Duc Trong Quach; Dao Thi-Hong Pham; Nga Minh Cao; Uyen Thi-Hong Nguyen; An Nguyen-Thanh Dang; Minh Anh Tran; Loc Huu Quach; Khiem Thien Tran; Nhan Quang Le; Viet Van Ung; Minh Ngoc-Quoc Vo; Danh Thanh Nguyen; Kha Dong Ngo; Trung Le Tran; Vy Thuy Nguyen
Journal:  BMC Microbiol       Date:  2022-02-03       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.